Neurizon Therapeutics Limited (ASX:NUZ)
Australia · Delayed Price · Currency is AUD 0.0960
-0.0020 (-2.04%)
Feb 19, 2026, 4:10 PM AEST
Neurizon Therapeutics Market Cap
Neurizon Therapeutics has a market cap or net worth of 67.49 million as of February 18, 2026. Its market cap has increased by 9.66% in one year.
Market Cap
67.49M
Enterprise Value
63.30M
Revenue
1.54M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.10
Market Cap Chart
Since September 12, 2002, Neurizon Therapeutics's market cap has increased from 4.18M to 67.49M, an increase of 1,513.25%. That is a compound annual growth rate of 12.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 66.11M | 45.16% |
| Dec 31, 2025 | 45.54M | -45.58% |
| Dec 31, 2024 | 83.69M | 94.55% |
| Dec 29, 2023 | 43.02M | 112.09% |
| Dec 30, 2022 | 20.28M | -36.00% |
| Dec 31, 2021 | 31.69M | -4.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arovella Therapeutics | 102.44M |
| LTR Pharma | 94.52M |
| Cynata Therapeutics | 90.66M |
| Alterity Therapeutics | 87.00M |
| Imugene | 80.38M |
| Radiopharm Theranostics | 77.97M |
| EZZ Life Science Holdings | 76.92M |
| Prescient Therapeutics | 67.30M |